FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis's generic buprenorphine and naloxone product under an original ANDA for the treatment of opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine and naloxone (BUPRENORPHINE AND NALOXONE)

Snippet

ORIG AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)